跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rapidon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rapidon
Approved
STANDARD
Rapidon
Micro Labs. Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
687d16f191a03af1
Company
Micro Labs. Limited
Type
Standard
Approval Details
Approval Id
687d16f191a03af1
Drug Approval Philippines Name
Rapidon
Product Name
Rapidon
Registration Number
DRP-7228
Brand Name
Rapidon
Generic Name
Olopatadine (as Hydrochloride)
Dosage Form
Ophthalmic Solution
Dosage Strength
1mg/ mL (0.1% w/v)
Manufacturer
Micro Labs. Limited
Importer
Brown & Burk Philippines Inc.
Distributor
Brown & Burk Philippines Inc.
Issuance Date
27 June 2022
Expiry Date
13 June 2027
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
687d16f191a03af1
Type
Standard
Back to Philippines FDA Approvals